C4BPB
Basic information
Region (hg38): 1:207088860-207099993
Previous symbols: [ "C4BP" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the C4BPB gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 13 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 6 | |||||
Total | 0 | 0 | 9 | 6 | 9 |
Variants in C4BPB
This is a list of pathogenic ClinVar variants found in the C4BPB region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-207089560-T-C | not specified | Uncertain significance (Aug 29, 2022) | ||
1-207089566-C-T | not specified | Likely benign (May 22, 2023) | ||
1-207089587-A-G | not specified | Uncertain significance (Jul 25, 2023) | ||
1-207089635-T-G | Benign (Nov 10, 2018) | |||
1-207090194-C-T | Benign (Jun 19, 2021) | |||
1-207090315-C-T | Benign (Jun 26, 2018) | |||
1-207090319-C-G | not specified | Uncertain significance (May 06, 2024) | ||
1-207090354-C-T | Benign (Jun 26, 2018) | |||
1-207090391-G-C | not specified | Likely benign (May 30, 2023) | ||
1-207090478-C-T | not specified | Uncertain significance (Sep 16, 2021) | ||
1-207090484-A-G | not specified | Benign (Nov 10, 2018) | ||
1-207091722-C-T | not specified | Uncertain significance (Dec 26, 2023) | ||
1-207091763-C-T | not specified | Likely benign (May 24, 2023) | ||
1-207091828-C-A | Likely benign (Jul 01, 2022) | |||
1-207092085-G-A | Benign (Jun 19, 2021) | |||
1-207096510-C-T | not specified | Benign (Mar 28, 2016) | ||
1-207096513-T-C | not specified | Benign (Jun 09, 2021) | ||
1-207096574-C-T | not specified | Benign (Jun 09, 2021) | ||
1-207098127-G-GCCTTGTTCTAATTTCTGTT | C4BPB-related disorder | Likely benign (Aug 14, 2023) | ||
1-207098166-G-A | C4BPB-related disorder | Likely benign (Feb 18, 2022) | ||
1-207098228-C-T | Likely benign (Jun 18, 2018) | |||
1-207098231-G-C | not specified | Uncertain significance (Dec 11, 2023) | ||
1-207098242-A-C | not specified | Uncertain significance (Jan 26, 2023) | ||
1-207098517-T-G | Benign (Jun 18, 2021) | |||
1-207099829-A-C | not specified | Uncertain significance (Nov 07, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
C4BPB | protein_coding | protein_coding | ENST00000243611 | 6 | 11152 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000440 | 0.655 | 125731 | 0 | 13 | 125744 | 0.0000517 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.463 | 120 | 135 | 0.888 | 0.00000674 | 1676 |
Missense in Polyphen | 23 | 33.171 | 0.69337 | 433 | ||
Synonymous | 0.117 | 48 | 49.0 | 0.979 | 0.00000277 | 431 |
Loss of Function | 0.870 | 8 | 11.1 | 0.719 | 5.56e-7 | 128 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000578 | 0.0000578 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000541 | 0.0000527 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000163 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Controls the classical pathway of complement activation. It binds as a cofactor to C3b/C4b inactivator (C3bINA), which then hydrolyzes the complement fragment C4b. It also accelerates the degradation of the C4bC2a complex (C3 convertase) by dissociating the complement fragment C2a. It also interacts with anticoagulant protein S and with serum amyloid P component. The beta chain binds protein S.;
- Pathway
- Complement and coagulation cascades - Homo sapiens (human);Pertussis - Homo sapiens (human);Innate Immune System;Immune System;FOXA1 transcription factor network;Regulation of Complement cascade;Complement cascade
(Consensus)
Recessive Scores
- pRec
- 0.133
Intolerance Scores
- loftool
- 0.962
- rvis_EVS
- 0.13
- rvis_percentile_EVS
- 63
Haploinsufficiency Scores
- pHI
- 0.0690
- hipred
- N
- hipred_score
- 0.123
- ghis
- 0.401
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.471
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- complement activation, classical pathway;blood coagulation;regulation of complement activation;innate immune response;positive regulation of protein catabolic process;negative regulation of complement activation, classical pathway;regulation of opsonization
- Cellular component
- extracellular region;extracellular space;plasma membrane;other organism cell
- Molecular function
- protein binding